IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 320 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $407,000 | -74.1% | 11,000 | -74.0% | 0.05% | +11.6% |
| Q1 2022 | $1,569,000 | +34.0% | 42,380 | +10.1% | 0.04% | +87.0% |
| Q4 2021 | $1,171,000 | -19.5% | 38,500 | -11.3% | 0.02% | -47.7% |
| Q3 2021 | $1,455,000 | -79.7% | 43,400 | -75.9% | 0.04% | -82.7% |
| Q2 2021 | $7,181,000 | +47.8% | 180,000 | +66.5% | 0.26% | +110.7% |
| Q1 2021 | $4,860,000 | +4.2% | 108,100 | +31.0% | 0.12% | +37.5% |
| Q4 2020 | $4,665,000 | +27.6% | 82,500 | +7.1% | 0.09% | -35.3% |
| Q3 2020 | $3,655,000 | +48.6% | 77,000 | +58.8% | 0.14% | -76.0% |
| Q3 2017 | $2,459,000 | – | 48,500 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |